NVE's Breakout Quarter Meets Its Reversion Test — With a New CEO and a Robot Bet Not Yet in the Numbers

A 67% distributor surge and a $1–$2 sensor pitch into humanoids, set against an 8% revenue decline and a stock 23% off its July peak.

NVEC · Earnings Call · 2026-10-21

The plateau question, answered for now

NVE's stock peaked at $134.21 on July 23 — the day after its last earnings call — on the back of a June quarter the filing shows at $11 million, up 81% year over year. It has given back 23% since, and the 90-day tape is a single down leg of roughly 10%. This report is the test of whether that June quarter was a new base or a timing artifact. The answer, for now, is artifact. On that prior call, Walter Morris of Silverberg Bernstein asked the exact question that has hung over this small-cap for years:

this was an explosive quarter ... periodically, we'll have a high single-digit, low double-digit revenue quarter. But at least up to now, there's been a reversion to the kind of $25 million annualized revenue run rate ... can you speak to the possibility or the likelihood that this represents a new higher, meaningfully higher plateau
Unknown Analyst, Analyst · 2026-07-22

The answer then was the familiar hedge — “we aren't able to give forward-looking guidance ... But I will say we're very optimistic” — Daniel Baker, President and CEO · 2026-07-22. Now we know the near-term shape: September-quarter revenue fell 8% year over year, net income $3.17 million or $0.65 per diluted share versus $3.3 million or $0.68. The run-rate is back near $6 million a quarter. That is the exact sawtooth Morris described. The offset is real, though. “a 67% increase in distributor sales” — Peter G. Eames · 2026-10-21 — the broadest read management has on genuine end-demand, after distributor destocking crushed the prior two years. The company-level miss came from two identifiable places: “The decrease in product sales was due to a short-term inventory adjustment at 1 of our large medical device customers. And a 95% decrease in defense product sales.” — Daniel Nelson · 2026-10-21 Management frames both as timing and guides the back half to look like the first — and the first half was genuinely strong at $16.9 million of revenue, up 36%, with $9.57 million of net income. The cause for caution is that H1 itself was flattered by orders pulled forward; the quarter that just disappointed is the payback for the quarter that thrilled.

A new voice, an old bet

This is Peter Eames's first call as CEO, with founder-CEO Daniel Baker moving to chairman and the board expanded from five to seven with Carolyn Valentine. The governance keywords — recent leadership transition, appointed president, Board expansion — are new this quarter and will recur. Strategically, though, Eames is running Baker's playbook: the wafer level chip scale products and new gear sensors families, aimed squarely at humanoid robotics and factory automation. Eames calls the gear-sensor timing "perfect with the growth in the humanoid robotics industry." Treat that as narrative, not revelation — robotics has been threaded through these calls since at least 2025, and the keyword history shows design wins and robotics themes rising for several quarters. What is new is quantification. The pitch is spatial sensitivity at a price point no competitor matches, and management finally sized it: “the ASP is perhaps $1 to $2 per sensor. And, obviously, there is several sensors used in the precision motion application of human robotics.” — Peter G. Eames · 2026-10-21 Pressed on whether "several" meant tens or hundreds, the answer was “Certainly in the tens ... I think, is fair.” — Peter G. Eames · 2026-10-21 That is real content per robot — but also a reminder of the math: at $1–$2 an ASP, this is a millions-of-units story, and the design-win cycle runs quarters. The prior call was candid about it: “The new products that most of the volume was in existing customers, but we also had new customers and they tend to start out a little bit more slowly.” — Daniel Baker, President and CEO · 2026-07-22 Nothing this quarter accelerated that clock, though management insists order sizes are rising.

The 800-volt thread and the tape's mood

Power conversion is the quiet second leg. NVE's isolators sit in high-voltage supplies and data-center power, and the global keyword set now carries an explicit 800V DC theme. But this is not a fresh catalyst for NVE — a year ago management was already making the same claim: “We have some of the highest isolation voltage ratings in the industry ... the voltages that you mentioned for data centers as well within our sweet spot.” — Peter Eames, Vice President of Advanced Technology · 2025-10-22 It remains a legitimate multi-year tailwind, and Eames restated it firmly — “we are definitely seeing strong growth in both power conversion and in robotics applications” — Peter G. Eames · 2026-10-21 — but the market's mood toward that whole complex has soured. The 90-day global tape shows the AI data-center basket with roughly 48 decliners against 6 advancers; adjacent packaging themes like co-package optics and high-bandwidth memory are down double-digit percentages over the same window. NVE's power story is riding a wave the tape is currently deflating.

What stopped being said, and what it's worth

The loudest absence is defense. In the March 2026 quarter, defense sales was the company's number-one keyword; this quarter it has fallen out of the top thirty entirely, replaced by talk of humanoids and gear teeth. Management was always explicit that defense is lumpy and not the growth engine — “it's not -- it's not really a key part of our growth strategy” — Daniel Baker, President and CEO · 2025-10-22 — so the 95% collapse reads as procurement timing rather than deterioration. But a keyword that led the deck two quarters ago vanishing into a one-line explanation is worth noting. Fundamentally, the franchise still prints money. Gross margin was 78% in the quarter, and the net margin of 54% is more optics than operating leverage: the effective tax rate fell to 14% from 20% on favorable tax-law changes, guided at 14–16% for the rest of the year. Strip that out and the earnings beat narrative thins. Valuation still assumes growth: Price to net income sits near 28x, and receivables to revenue jumped to 59.3% — consistent with management's disclosure that September was the strongest month of the quarter. So the honest read: NVE's underlying business — Distributor sales recovering, patented spintronics, high-margin niche sensors — is healthier than the 8% headline, and the robotics option is more quantified than ever. But the "new plateau" thesis the market briefly paid $134 a share for is not in the numbers yet. Eames inherits a good company, a fair narrative, and an impatient chart.